611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...

Basic InformationLatest News
How Insurance Plans Keep Black Patients From Cancer CareStatins Tied to Significantly Lower Death Rate From Ovarian CancerNew Blood Test May Improve Liver Cancer ScreeningCancer Patients Less Likely to Be Prescribed Heart Meds: StudyBreast Cancer Takes Big Financial Toll on Some Young PatientsLoving Partners May Be Key to Breast Cancer Survivors' Health'Lab-on-a-Chip' Blood Test Could Spot Breast Cancer EarlyBlack Melanoma Patients Face Treatment Delays: StudyLatest in Cancer Prevention: Move More, Ditch Beer and BaconAt-Home Gene Test for Breast, Ovarian Cancers Looks EffectiveDrug Could Boost Survival From Lung Cancer Affecting Non-SmokersProtect Yourself From Sun to Prevent Skin CancerVery Early-Stage Breast Cancer Ups Long-Term Odds for Invasive Tumors: StudyHydroxychloroquine May Worsen Odds for Cancer Patients With COVID-19Tumors Have Their Own Bacterial Colonies That Could Guide Cancer Care'Major Financial Hardship' Hits Most Patients Battling Advanced Colon CancerAs Summer Starts, Sun Safety Slashes Skin Cancer RiskChild's Cancer Doesn't Raise Parents' Divorce Risk, Curb Plans for More Kids: StudyWith PSA Test Out of Favor, Cases of Advanced Prostate Cancer Are RisingBlack and White Women Share the Same Genetic Risk for Breast CancerKids With Cancer Not at Greater Risk for Severe COVID-19Don't Delay If Cancer Symptoms Appear – Call Your DoctorObamacare's Medicaid Expansion Might Have Cut U.S. Cancer DeathsDrug Combo Offers Hope Against Advanced Bladder CancerPandemic Is Putting Cutting-Edge Cancer Research on Hold: SurveyFDA Approves Retevmo for Certain Lung, Thyroid CancersBreaks in Health Insurance Hurt Cancer Care, SurvivalFewer Kids in Cancer Trials, Which Might Not Be a Bad ThingShun the Sun to Prevent Skin CancerCould AI Help Doctors Map Out Treatments for Brain Cancers?FDA Approves Trodelvy for Metastatic Triple-Negative Breast CancerBacterial Blood Infections Tied to Heightened Colon Cancer RiskPemazyre Approved for Treatment of Advanced CholangiocarcinomaTukysa Approved for Unresectable, Metastatic HER2-Positive Breast CancerParent or Sibling With Colon Cancer? You May Need Colonoscopy EarlierBreast Cancer Group Issues Treatment Guidelines for Coronavirus PandemicBlood Test Might Spot Pancreatic Cancer EarlyLow-Dose Aspirin Might Lower Odds for Digestive CancersIn Nonsmokers, COPD May Up Lung Cancer RiskBlood Test Could Spot 50 Different CancersCOVID-19 May Force Some Cancer Patients to Delay TreatmentCoping With Cancer During the COVID-19 PandemicStatins Might Reduce Harms From Breast Cancer ChemoU.S. Sees Big Drop in Deaths From MelanomaCertain Cancers Linked to Higher A-Fib Risk, Study FindsRacial Bias Persists in Clinical Trial RecruitmentMinorities Less Likely to Get Recommended Lung Cancer ImagingExercise Helps Men During Hormone Treatment for Prostate Cancer: Study5 Ways to Fight America's No. 3 Cancer KillerProstate Cancer Leaves Detectable 'Fingerprint' in Blood: Study
LinksBook ReviewsSelf-Help Groups
Related Topics

Medical Disorders
Pain Management

Obamacare's Medicaid Expansion Might Have Cut U.S. Cancer Deaths

HealthDay News
by -- Robert Preidt
Updated: May 15th 2020

new article illustration

FRIDAY, May 15, 2020 (HealthDay News) -- Cancer death rates have declined more in U.S. states that expanded Medicaid after the Affordable Care Act than in those that didn't, a new study finds.

"This is the first study to show the benefit of Medicaid expansion on cancer death rates on a national scale," said lead author Dr. Anna Lee, a radiation oncology fellow at Memorial Sloan Kettering Cancer Center in New York City.

"We now have evidence that Medicaid expansion has saved the lives of many people with cancer across the United States," she added.

Medicaid expansion is part of the Affordable Care Act enacted in 2010. At the time of the analysis, 27 states and the District of Columbia had adopted Medicaid expansion, while 23 states did not.

In the study, Lee's team analyzed nationwide data from 1999 to 2017 and found a 29% decline in cancer deaths in states that expanded Medicaid, from 65.1 to 46.3 per 100,000 people.

In states that didn't expand Medicaid, there was a 25% decline, from 69.5 to 52.3 per 100,000 people.

The additional benefits for states that expanded Medicaid amounted to an estimated 785 fewer cancer deaths in 2017 alone. The findings will be presented this week at a virtual meeting of the American Society of Clinical Oncologists (ASCO). Such research is considered preliminary until published in a peer-reviewed journal.

"This study provides needed data to understand the effects of Medicaid expansion on cancer care. Better access to quality cancer care, in this case through state expansion of Medicaid, leads to fewer cancer deaths," Dr. Richard Schilsky, ASCO chief medical officer and executive vice president, said in a meeting news release.

The study authors also examined changes in cancer death rates among specific groups, including blacks and Hispanics.

While there were significant declines in cancer deaths among blacks nationwide, no additional declines were seen in states that expanded Medicaid. However, cancer death rates were consistently worse for blacks in states without expansion than in states with expansion, 63.4 vs. 58.5 per 100,000, respectively.

In contrast, the researchers found that the greatest change in cancer death rates between expansion and non-expansion states was seen for Hispanics.

"There is a greater Hispanic population in states that have adopted Medicaid expansion, and they have almost three times the un-insurance rate as white adults," said senior study author Dr. Fumiko Chino, a radiation oncologist at Memorial Sloan Kettering.

"Our research shows that Hispanic patients with cancer may have benefited the most because they had the most to gain," she explained in the release.

More information

The U.S. National Cancer Institute has more on cancer.